These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36824724)

  • 21. Volume regulation and KCl cotransport in reticulocyte populations of sickle and normal red blood cells.
    Quarmyne MO; Risinger M; Linkugel A; Frazier A; Joiner C
    Blood Cells Mol Dis; 2011 Aug; 47(2):95-9. PubMed ID: 21576026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A miniaturized wash-free microfluidic assay for electrical impedance-based assessment of red blood cell-mediated microvascular occlusion.
    Oshabaheebwa S; Delianides CA; Patwardhan AA; Evans EN; Sekyonda Z; Bode A; Apio FM; Mutuluuza CK; Sheehan VA; Suster MA; Gurkan UA; Mohseni P
    Biosens Bioelectron; 2024 Aug; 258():116352. PubMed ID: 38718635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acquired hemoglobin variants and exposure to glucose-6-phosphate dehydrogenase deficient red blood cell units during exchange transfusion for sickle cell disease in a patient requiring antigen-matched blood.
    Raciti PM; Francis RO; Spitalnik PF; Schwartz J; Jhang JS
    J Clin Apher; 2013 Aug; 28(4):325-9. PubMed ID: 23450789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GBT021601 improves red blood cell health and the pathophysiology of sickle cell disease in a murine model.
    Dufu K; Alt C; Strutt S; Partridge J; Tang T; Siu V; Liao-Zou H; Rademacher P; Williams AT; Muller CR; Geng X; Pochron MP; Dang AN; Cabrales P; Li Z; Oksenberg D; Cathers BE
    Br J Haematol; 2023 Jul; 202(1):173-183. PubMed ID: 36960712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic impact of red blood cell exchange with rejuvenated red blood cells in sickle cell patients.
    Gehrke S; Shah N; Gamboni F; Kamyszek R; Srinivasan AJ; Gray A; Landrigan M; Welsby I; D'Alessandro A
    Transfusion; 2019 Oct; 59(10):3102-3112. PubMed ID: 31385330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of repleting organic phosphates in banked erythrocytes on plasma metabolites and vasoactive mediators after red cell exchange transfusion in sickle cell disease.
    Lopez Domowicz DA; Welsby I; Esther CR; Zhu H; Marek RD; Lee G; Shah N; Poisson JL; McMahon TJ
    Blood Transfus; 2020 May; 18(3):200-207. PubMed ID: 32203007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune erythrocyte antibodies in adult patients with sickle cell disease and blood donors in Lagos, Nigeria: a comparative study.
    Adewoyin AS; Daramola OA; Ogbenna AA; Adeyemo TA
    Immunohematology; 2021 Sep; 37(3):131-137. PubMed ID: 34591378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemoglobin A clearance in children with sickle cell anemia on chronic transfusion therapy.
    Yee MEM; Josephson CD; Winkler AM; Webb J; Luban NLC; Leong T; Stowell SR; Roback JD; Fasano RM
    Transfusion; 2018 Jun; 58(6):1363-1371. PubMed ID: 29664198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pyruvate kinase activators: targeting red cell metabolism in sickle cell disease.
    Xu JZ; Vercellotti GM
    Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):107-113. PubMed ID: 38066891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mathematical calculation of lifespan of transfused RBCs in sickle cell disease patients.
    Kim J; Usmani A; De Simone N; Sarode R
    Transfus Apher Sci; 2018 Feb; 57(1):46-49. PubMed ID: 29196100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interval decline in hemoglobin A is associated with annual clinical event rate in sickle cell anemia patients receiving maintenance apheresis RBC exchange.
    Kamyszek RW; Raval JS; Srinivasan AJ; Ansari AK; Evans BA; Rollins-Raval MA; Poisson JL; Shah NR; Welsby IJ
    Transfusion; 2019 Aug; 59(8):2622-2628. PubMed ID: 31161685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucose-6-phosphate dehydrogenase deficiency is more prevalent in Duffy-null red blood cell transfusion in sickle cell disease.
    Yee ME; Francis RO; Luban NLC; Easley KA; Lough CM; Roback JD; Josephson CD; Fasano RM
    Transfusion; 2022 Mar; 62(3):551-555. PubMed ID: 35044697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolomics of ADSOL (AS-1) red blood cell storage.
    Roback JD; Josephson CD; Waller EK; Newman JL; Karatela S; Uppal K; Jones DP; Zimring JC; Dumont LJ
    Transfus Med Rev; 2014 Apr; 28(2):41-55. PubMed ID: 24636780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GBT440 improves red blood cell deformability and reduces viscosity of sickle cell blood under deoxygenated conditions.
    Dufu K; Patel M; Oksenberg D; Cabrales P
    Clin Hemorheol Microcirc; 2018; 70(1):95-105. PubMed ID: 29660913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alloimmunization to transfused HOD red blood cells is not increased in mice with sickle cell disease.
    Hendrickson JE; Hod EA; Perry JR; Ghosh S; Chappa P; Adisa O; Kean LS; Ofori-Acquah SF; Archer DR; Spitalnik SL; Zimring JC
    Transfusion; 2012 Feb; 52(2):231-40. PubMed ID: 21790627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating platelet and erythrocyte microparticles in young children and adolescents with sickle cell disease: Relation to cardiovascular complications.
    Tantawy AA; Adly AA; Ismail EA; Habeeb NM; Farouk A
    Platelets; 2013; 24(8):605-14. PubMed ID: 23249216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delayed hemolytic transfusion reaction in sickle cell disease patients: evidence of an emerging syndrome with suicidal red blood cell death.
    Chadebech P; Habibi A; Nzouakou R; Bachir D; Meunier-Costes N; Bonin P; Rodet M; Chami B; Galacteros F; Bierling P; Noizat-Pirenne F
    Transfusion; 2009 Sep; 49(9):1785-92. PubMed ID: 19413729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low concentrations of nitric oxide increase oxygen affinity of sickle erythrocytes in vitro and in vivo.
    Head CA; Brugnara C; Martinez-Ruiz R; Kacmarek RM; Bridges KR; Kuter D; Bloch KD; Zapol WM
    J Clin Invest; 1997 Sep; 100(5):1193-8. PubMed ID: 9276736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hydroxyurea: Clinical and Hematological Effects in Patients With Sickle Cell Anemia.
    Keikhaei B; Yousefi H; Bahadoram M
    Glob J Health Sci; 2015 Aug; 8(3):252-6. PubMed ID: 26493428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FT-4202, an oral PKR activator, has potent antisickling effects and improves RBC survival and Hb levels in SCA mice.
    Shrestha A; Chi M; Wagner K; Malik A; Korpik J; Drake A; Fulzele K; Guichard S; Malik P
    Blood Adv; 2021 May; 5(9):2385-2390. PubMed ID: 33944896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.